FROVATRIPTAN SUCCINATE

FROVATRIPTAN SUCCINATE was reported 798 times

FROVATRIPTAN SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEOVASCULARISATION 55 0.2091
1 CIRCULATING ANTICOAGULANT 1 0.0526
2 HAIR METAL TEST ABNORMAL 1 0.0323
3 DEVICE TOXICITY 1 0.0238
4 ABNORMAL CORD INSERTION 1 0.0200
5 BLOOD TESTOSTERONE FREE INCREASED 1 0.0167
6 HYPERPLASIA ADRENAL 1 0.0159
7 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 42 0.0158
8 PARADOXICAL DRUG REACTION 55 0.0149
9 NONREASSURING FOETAL HEART RATE PATTERN 3 0.0135
10 TOOTH SOCKET HAEMORRHAGE 3 0.0125
11 POST VIRAL FATIGUE SYNDROME 3 0.0124
12 PLASTIC SURGERY TO THE FACE 1 0.0120
13 PALATE INJURY 1 0.0120
14 GINGIVAL PRURITUS 1 0.0116
15 BRCA2 GENE MUTATION 1 0.0105
16 BENIGN GASTROINTESTINAL NEOPLASM 1 0.0105
17 FACTOR V LEIDEN MUTATION 4 0.0101
18 SYNDACTYLY 8 0.0096
19 CONGENITAL INGUINAL HERNIA 2 0.0096
20 SUPERIOR MESENTERIC ARTERY SYNDROME 2 0.0090
21 DUST ALLERGY 8 0.0082
22 BURNS THIRD DEGREE 8 0.0076
23 LICHEN PLANUS 17 0.0073
24 SWOLLEN TONGUE 217 0.0069
25 ANURIA 55 0.0064
26 BRACHIAL PLEXUS INJURY 1 0.0062
27 BROW PTOSIS 4 0.0061
28 NASAL DISCHARGE DISCOLOURATION 8 0.0058
29 BRONCHIAL OBSTRUCTION 8 0.0057
30 URTICARIA CHRONIC 3 0.0053
31 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
32 EPIDURAL INJECTION 1 0.0051
33 BRACHYDACTYLY 1 0.0051
34 ANGIOEDEMA 214 0.0048
35 ANEMBRYONIC GESTATION 1 0.0048
36 NASAL OEDEMA 8 0.0044
37 CERVICAL CYST 1 0.0042
38 BURNING FEET SYNDROME 1 0.0040
39 GINGIVAL EROSION 1 0.0039
40 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 211 0.0038
41 IMMUNOGLOBULINS ABNORMAL 1 0.0038
42 THORACIC OUTLET SYNDROME 1 0.0037
43 MICROPHTHALMOS 1 0.0037
44 DYSPHONIA 213 0.0036
45 ANGIOGRAM 1 0.0036
46 PERIPHERAL ARTERY THROMBOSIS 5 0.0036
47 ANDROGENETIC ALOPECIA 1 0.0035
48 MOTOR DEVELOPMENTAL DELAY 2 0.0035
49 BACTERIAL VULVOVAGINITIS 1 0.0035
50 SWELLING FACE 218 0.0033
51 GASTROINTESTINAL BACTERIAL OVERGROWTH 2 0.0033
52 FEMORAL ARTERY OCCLUSION 1 0.0032
53 COLORECTAL ADENOMA 1 0.0031
54 CATHETER SITE IRRITATION 1 0.0030
55 BLOOD OESTROGEN DECREASED 2 0.0028
56 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
57 PRODUCT DOSE CONFUSION 1 0.0028
58 RENAL INFARCT 4 0.0028
59 NON-SMALL CELL LUNG CANCER STAGE IV 1 0.0027
60 OBSESSIVE-COMPULSIVE SYMPTOM 1 0.0027
61 HEMIPARAESTHESIA 1 0.0026
62 PULMONARY ARTERY STENOSIS 1 0.0026
63 PULSE ABNORMAL 6 0.0025
64 SPHINCTER OF ODDI DYSFUNCTION 1 0.0024
65 PYRAMIDAL TRACT SYNDROME 1 0.0024
66 HEART VALVE OPERATION 1 0.0023
67 DRUG INTOLERANCE 222 0.0023
68 GASTROINTESTINAL FISTULA 2 0.0023
69 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
70 EXTRAPYRAMIDAL DISORDER 55 0.0022
71 ALLERGY TO PLANTS 1 0.0022
72 PHONOPHOBIA 1 0.0022
73 EHLERS-DANLOS SYNDROME 1 0.0022
74 BLOOD UREA ABNORMAL 2 0.0021
75 HEPATIC HAEMATOMA 1 0.0021
76 PIGMENTARY MACULOPATHY 1 0.0021
77 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
78 MORNING SICKNESS 1 0.0018
79 TUMOUR RUPTURE 1 0.0018
80 UTERINE CYST 1 0.0018
81 LARYNGEAL STENOSIS 1 0.0017
82 ADRENAL ADENOMA 1 0.0017
83 SPONDYLOARTHROPATHY 1 0.0017
84 HYDROPS FOETALIS 1 0.0016
85 HYPERACUSIS 6 0.0016
86 JOINT WARMTH 2 0.0016
87 CLEFT PALATE 3 0.0016
88 SHORT-BOWEL SYNDROME 1 0.0015
89 SMALL INTESTINE ULCER 1 0.0015
90 MITE ALLERGY 1 0.0015
91 PHAEOCHROMOCYTOMA 1 0.0015
92 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
93 MACULAR FIBROSIS 1 0.0015
94 CLUSTER HEADACHE 2 0.0015
95 INFUSION SITE RASH 2 0.0015
96 RENAL APLASIA 1 0.0014
97 FUNGAL OESOPHAGITIS 1 0.0014
98 JAUNDICE CHOLESTATIC 5 0.0014
99 TENSION HEADACHE 6 0.0014
100 INFUSION SITE BRUISING 3 0.0014
101 DRUG-DISEASE INTERACTION 1 0.0014
102 MIGRAINE 128 0.0013
103 ALLERGIC COUGH 1 0.0013
104 MUSCLE DISCOMFORT 1 0.0013
105 INFUSION SITE HAEMORRHAGE 4 0.0012
106 ADRENAL MASS 1 0.0012
107 HYPERSENSITIVITY 223 0.0012
108 INFUSION SITE OEDEMA 1 0.0012
109 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
110 MYCOTIC ALLERGY 1 0.0012
111 MEDICATION OVERUSE HEADACHE 1 0.0012
112 CORONARY ARTERY DISSECTION 1 0.0012
113 LUNG HYPERINFLATION 1 0.0012
114 SPUTUM DISCOLOURED 11 0.0012
115 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
116 MAJOR DEPRESSION 8 0.0011
117 FOETAL HEART RATE ABNORMAL 1 0.0011
118 RAYNAUD'S PHENOMENON 1 0.0011
119 THERAPEUTIC RESPONSE INCREASED 1 0.0011
120 PELVIC DISCOMFORT 1 0.0011
121 INJECTION SITE SCAB 1 0.0010
122 HAEMANGIOMA OF LIVER 1 0.0010
123 SPONTANEOUS HAEMORRHAGE 1 0.0010
124 BLADDER DYSFUNCTION 1 0.0010
125 ALLERGY TO ANIMAL 1 0.0009
126 IMMEDIATE POST-INJECTION REACTION 1 0.0009
127 OTITIS MEDIA 3 0.0009
128 EAR DISCOMFORT 9 0.0009
129 TEMPERATURE INTOLERANCE 9 0.0009
130 POLYDACTYLY 1 0.0009
131 HYPERTENSIVE EMERGENCY 1 0.0008
132 EYE INFLAMMATION 8 0.0008
133 EYE HAEMORRHAGE 11 0.0008
134 APPLICATION SITE WARMTH 1 0.0008
135 MICROCEPHALY 1 0.0008
136 THERAPY PARTIAL RESPONDER 12 0.0008
137 FEELINGS OF WORTHLESSNESS 1 0.0008
138 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
139 CYSTITIS NONINFECTIVE 1 0.0007
140 PREMENSTRUAL SYNDROME 1 0.0007
141 RENAL ARTERY STENOSIS 1 0.0007
142 SUDDEN ONSET OF SLEEP 1 0.0007
143 EXTRASYSTOLES 5 0.0007
144 PERIODONTAL DISEASE 1 0.0007
145 MAST CELL ACTIVATION SYNDROME 1 0.0007
146 TREATMENT FAILURE 59 0.0007
147 SEASONAL ALLERGY 10 0.0007
148 AUDITORY DISORDER 1 0.0007
149 BLOOD ELECTROLYTES DECREASED 1 0.0007
150 ANGIOPLASTY 1 0.0007
151 INFERTILITY 1 0.0007
152 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
153 IRITIS 2 0.0007
154 POLYCYSTIC OVARIES 1 0.0006
155 RESPIRATORY RATE DECREASED 2 0.0006
156 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
157 INTRA-UTERINE DEATH 1 0.0006
158 CYSTITIS INTERSTITIAL 1 0.0006
159 DIPLOPIA 16 0.0006
160 MEDICAL PROCEDURE 1 0.0006
161 IMPAIRED GASTRIC EMPTYING 8 0.0006
162 FEMORAL NECK FRACTURE 3 0.0006
163 MASTECTOMY 1 0.0006
164 INFUSION SITE DISCHARGE 1 0.0006
165 DYSPEPSIA 56 0.0006
166 DEPRESSIVE SYMPTOM 2 0.0006
167 FOOD INTERACTION 1 0.0006
168 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
169 HYPERTRICHOSIS 1 0.0005
170 TUNNEL VISION 1 0.0005
171 SNORING 2 0.0005
172 GINGIVAL RECESSION 1 0.0005
173 MOTION SICKNESS 1 0.0005
174 RHEUMATIC DISORDER 1 0.0005
175 PANIC DISORDER 2 0.0005
176 EAR PAIN 10 0.0005
177 ABDOMINAL WALL HAEMATOMA 1 0.0005
178 ORAL INFECTION 2 0.0005
179 JOINT NOISE 1 0.0005
180 LIPIDS INCREASED 1 0.0005
181 HYPERAESTHESIA 4 0.0005
182 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
183 PRE-EXISTING CONDITION IMPROVED 3 0.0005
184 TENDERNESS 5 0.0005
185 DRUG USE DISORDER 4 0.0005
186 INCONTINENCE 5 0.0005
187 EAR SWELLING 1 0.0005
188 PRODUCT USE IN UNAPPROVED INDICATION 117 0.0005
189 LIPODYSTROPHY ACQUIRED 1 0.0005
190 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
191 DEREALISATION 1 0.0005
192 INJECTION SITE INDENTATION 1 0.0005
193 REACTION TO DRUG EXCIPIENTS 1 0.0005
194 APPLICATION SITE URTICARIA 1 0.0004
195 BRONCHIECTASIS 3 0.0004
196 HEADACHE 275 0.0004
197 MENOPAUSAL SYMPTOMS 1 0.0004
198 THERMAL BURN 3 0.0004
199 DERMATITIS BULLOUS 3 0.0004
200 THROAT TIGHTNESS 11 0.0004
201 ABNORMAL WEIGHT GAIN 5 0.0004
202 INFREQUENT BOWEL MOVEMENTS 1 0.0004
203 INJECTION SITE INFLAMMATION 2 0.0004
204 TACHYARRHYTHMIA 1 0.0004
205 CATHETER SITE HAEMORRHAGE 1 0.0004
206 MENOPAUSE 1 0.0004
207 COGNITIVE DISORDER 18 0.0004
208 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
209 ALCOHOL POISONING 1 0.0004
210 ANORGASMIA 1 0.0004
211 GASTRIC ULCER 7 0.0004
212 LIVE BIRTH 3 0.0004
213 TRICHORRHEXIS 1 0.0004
214 ELECTRIC SHOCK SENSATION 1 0.0004
215 OCULAR DISCOMFORT 4 0.0004
216 FIBULA FRACTURE 1 0.0003
217 SEDATION 9 0.0003
218 URINE OUTPUT DECREASED 3 0.0003
219 ABORTION 1 0.0003
220 REBOUND ACID HYPERSECRETION 1 0.0003
221 OPTIC NEURITIS 3 0.0003
222 OFF LABEL USE 288 0.0003
223 SPINAL OPERATION 4 0.0003
224 TALIPES 1 0.0003
225 INJECTION SITE DISCOLOURATION 4 0.0003
226 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
227 PHOTOPSIA 2 0.0003
228 STUPOR 1 0.0003
229 HAEMOGLOBIN ABNORMAL 2 0.0003
230 LOOSE TOOTH 1 0.0003
231 HEART RATE IRREGULAR 7 0.0003
232 FACET JOINT SYNDROME 1 0.0003
233 RESPIRATORY TRACT INFECTION 8 0.0003
234 TOOTH INFECTION 4 0.0003
235 PANIC ATTACK 11 0.0003
236 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
237 CHOLECYSTITIS CHRONIC 2 0.0003
238 BLOOD PRESSURE FLUCTUATION 7 0.0003
239 FORMICATION 2 0.0003
240 CAROTID ARTERY STENOSIS 1 0.0003
241 EAR PRURITUS 1 0.0003
242 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
243 HANGOVER 1 0.0003
244 HEAD DISCOMFORT 5 0.0003
245 SCLERODERMA 1 0.0003
246 BLINDNESS TRANSIENT 2 0.0003
247 EYE SWELLING 10 0.0003
248 GENERAL SYMPTOM 2 0.0003
249 DERMATITIS CONTACT 3 0.0003
250 ABDOMINAL PAIN 61 0.0003
251 WITHDRAWAL SYNDROME 11 0.0003
252 TINNITUS 12 0.0003
253 COUGH 73 0.0003
254 GINGIVAL DISORDER 1 0.0003
255 OESOPHAGEAL DISORDER 1 0.0003
256 FOOD ALLERGY 2 0.0003
257 CONCUSSION 2 0.0003
258 POST PROCEDURAL HAEMORRHAGE 3 0.0003
259 SPINAL CORD COMPRESSION 1 0.0003
260 MUSCLE RUPTURE 1 0.0003
261 GASTROINTESTINAL INFLAMMATION 2 0.0003
262 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
263 WEIGHT DECREASED 71 0.0003
264 COVID-19 PNEUMONIA 3 0.0003
265 POLYDIPSIA 1 0.0003
266 PRODUCTIVE COUGH 12 0.0003
267 NECK PAIN 14 0.0003
268 EYE PAIN 14 0.0002
269 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
270 PERIPHERAL VENOUS DISEASE 1 0.0002
271 SELF-MEDICATION 1 0.0002
272 SEIZURE 28 0.0002
273 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
274 SLEEP TERROR 1 0.0002
275 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
276 HYSTERECTOMY 2 0.0002
277 IMMOBILE 1 0.0002
278 BRAIN NEOPLASM MALIGNANT 1 0.0002
279 CHROMATURIA 5 0.0002
280 DRUG EFFECT DELAYED 1 0.0002
281 ISCHAEMIA 1 0.0002
282 EYE OPERATION 1 0.0002
283 IRON DEFICIENCY ANAEMIA 2 0.0002
284 PRE-ECLAMPSIA 1 0.0002
285 FEELING JITTERY 4 0.0002
286 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
287 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
288 PRESYNCOPE 5 0.0002
289 CEREBRAL INFARCTION 5 0.0002
290 COELIAC DISEASE 2 0.0002
291 LIVER INJURY 5 0.0002
292 APPLICATION SITE BURN 1 0.0002
293 HYPERVOLAEMIA 1 0.0002
294 ABDOMINAL TENDERNESS 1 0.0002
295 OVARIAN CYST 2 0.0002
296 HYPOAESTHESIA ORAL 3 0.0002
297 DYSLIPIDAEMIA 1 0.0002
298 FOETAL EXPOSURE DURING PREGNANCY 16 0.0002
299 DRUG LEVEL DECREASED 2 0.0002
300 INJECTION SITE RASH 6 0.0002
301 TRISMUS 1 0.0002
302 BRAIN FOG 3 0.0002
303 INTENTIONAL DRUG MISUSE 4 0.0002
304 FOLLICULITIS 2 0.0002
305 FOOD CRAVING 1 0.0002
306 OVERWEIGHT 1 0.0002
307 BRUXISM 1 0.0002
308 SKIN LACERATION 2 0.0002
309 MOOD ALTERED 5 0.0002
310 JAW DISORDER 1 0.0002
311 NONSPECIFIC REACTION 1 0.0002
312 ASTHENOPIA 1 0.0002
313 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
314 CYSTIC FIBROSIS 1 0.0002
315 INJECTION SITE INJURY 1 0.0002
316 TOOTH DISORDER 4 0.0002
317 URINARY RETENTION 6 0.0002
318 HEART RATE ABNORMAL 1 0.0002
319 MALNUTRITION 2 0.0002
320 SKIN INFECTION 2 0.0002
321 CANDIDA INFECTION 3 0.0002
322 COLECTOMY 1 0.0002
323 GENERALISED ERYTHEMA 1 0.0002
324 VENTRICULAR SEPTAL DEFECT 1 0.0002
325 ELECTROLYTE IMBALANCE 2 0.0002
326 SKIN WARM 1 0.0002
327 PRODUCT LABEL CONFUSION 1 0.0002
328 PRODUCT USE ISSUE 32 0.0002
329 RHINORRHOEA 11 0.0002
330 ATAXIA 2 0.0002
331 DRUG INEFFECTIVE 221 0.0002
332 MOBILITY DECREASED 12 0.0002
333 INFUSION RELATED REACTION 11 0.0002
334 INJECTION SITE VESICLES 1 0.0002
335 INGUINAL HERNIA 1 0.0002
336 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
337 LUNG DISORDER 8 0.0002
338 MENISCUS INJURY 1 0.0002
339 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
340 PHOTOPHOBIA 3 0.0002
341 DYSPNOEA 90 0.0002
342 INFUSION SITE SWELLING 1 0.0002
343 BLEPHAROSPASM 1 0.0002
344 SINUSITIS 16 0.0002
345 BREAST CANCER STAGE III 1 0.0002
346 HYPERPROLACTINAEMIA 1 0.0002
347 HEPATITIS ACUTE 1 0.0002
348 HAEMORRHOIDS 3 0.0002
349 NASAL CONGESTION 9 0.0002
350 NERVOUSNESS 8 0.0002
351 CHOLELITHIASIS 5 0.0002
352 WHEEZING 9 0.0002
353 ANKYLOSING SPONDYLITIS 2 0.0002
354 INJECTION SITE BRUISING 12 0.0002
355 EAR INFECTION 4 0.0002
356 JOINT RANGE OF MOTION DECREASED 2 0.0001
357 BRONCHITIS 11 0.0001
358 COLITIS ISCHAEMIC 1 0.0001
359 POSTOPERATIVE WOUND INFECTION 1 0.0001
360 PALLOR 4 0.0001
361 ABNORMAL LOSS OF WEIGHT 1 0.0001
362 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
363 EYE MOVEMENT DISORDER 1 0.0001
364 INJECTION SITE WARMTH 3 0.0001
365 INJECTION SITE SWELLING 11 0.0001
366 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
367 IMPAIRED WORK ABILITY 3 0.0001
368 INJECTION SITE HAEMATOMA 2 0.0001
369 FLUSHING 14 0.0001
370 ORAL DISORDER 1 0.0001
371 MOUTH HAEMORRHAGE 1 0.0001
372 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
373 ARTHROPOD BITE 1 0.0001
374 DUODENAL ULCER PERFORATION 1 0.0001
375 SNEEZING 3 0.0001
376 HAEMODYNAMIC INSTABILITY 1 0.0001
377 NAUSEA 103 0.0001
378 PELVIC FRACTURE 1 0.0001
379 DEPRESSION 29 0.0001
380 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
381 PRODUCT USE COMPLAINT 2 0.0001
382 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
383 FURUNCLE 1 0.0001
384 GINGIVAL PAIN 1 0.0001
385 ATRIAL FLUTTER 1 0.0001
386 ASTHMA 14 0.0001
387 MUSCLE TIGHTNESS 2 0.0001
388 NEURALGIA 3 0.0001
389 ASPHYXIA 1 0.0001
390 DIARRHOEA 79 0.0001
391 INJECTION SITE URTICARIA 3 0.0001
392 POLYURIA 1 0.0001
393 ABNORMAL FAECES 1 0.0001
394 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
395 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
396 PARAESTHESIA 19 0.0001
397 RHABDOMYOLYSIS 5 0.0001
398 INJECTION SITE PRURITUS 8 0.0001
399 ATRIAL SEPTAL DEFECT 1 0.0001
400 EYE PRURITUS 4 0.0001
401 FACIAL PARALYSIS 1 0.0001
402 PSEUDOMONAS INFECTION 1 0.0001
403 SKIN HYPERPIGMENTATION 1 0.0001
404 INJECTION SITE REACTION 8 0.0001
405 BLOOD MAGNESIUM DECREASED 1 0.0001
406 MUSCLE STRAIN 1 0.0001
407 PYELONEPHRITIS 1 0.0001
408 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
409 NAIL DISORDER 1 0.0001
410 GASTRITIS 3 0.0001
411 PURPURA 1 0.0001
412 GALLBLADDER DISORDER 2 0.0001
413 FACIAL PAIN 1 0.0001
414 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
415 OROPHARYNGEAL DISCOMFORT 1 0.0001
416 LUPUS-LIKE SYNDROME 1 0.0001
417 EXOSTOSIS 1 0.0001
418 INSOMNIA 29 0.0001
419 INCREASED TENDENCY TO BRUISE 1 0.0001
420 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
421 MENTAL STATUS CHANGES 3 0.0001
422 BLOOD CHOLESTEROL INCREASED 5 0.0001
423 DIARRHOEA HAEMORRHAGIC 1 0.0001
424 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
425 FLANK PAIN 1 0.0001
426 ABORTION INDUCED 1 0.0001
427 HYPOCALCAEMIA 2 0.0001
428 SPINAL DISORDER 1 0.0001
429 PRODUCT PACKAGING ISSUE 1 0.0001
430 MULTIPLE SCLEROSIS 5 0.0001
431 HYPERCHOLESTEROLAEMIA 1 0.0001
432 DYSSTASIA 3 0.0001
433 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
434 KIDNEY INFECTION 2 0.0001
435 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
436 THERAPY CHANGE 1 0.0001
437 LIGAMENT SPRAIN 1 0.0001
438 SINUS DISORDER 2 0.0001
439 BLOOD PRESSURE ABNORMAL 2 0.0001
440 VERTIGO 6 0.0001
441 EYELID PTOSIS 1 0.0001
442 EUPHORIC MOOD 1 0.0001
443 OSTEOPOROSIS 4 0.0001
444 DRUG-INDUCED LIVER INJURY 3 0.0001
445 INJECTION SITE DISCOMFORT 1 0.0001
446 HEAD INJURY 3 0.0001
447 JOINT DISLOCATION 1 0.0001
448 CYSTITIS 3 0.0001
449 LOSS OF CONSCIOUSNESS 12 0.0001
450 HYPOAESTHESIA 14 0.0001
451 RECTAL HAEMORRHAGE 4 0.0001
452 MENSTRUATION DELAYED 1 0.0001
453 BIPOLAR DISORDER 1 0.0001
454 BACK INJURY 1 0.0001
455 ANXIETY 26 0.0001
456 WOUND INFECTION 1 0.0001
457 GASTROINTESTINAL PAIN 1 0.0001
458 HEART RATE INCREASED 9 0.0001
459 TOOTH FRACTURE 1 0.0001
460 HYPERTENSIVE CRISIS 1 0.0001
461 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
462 RASH PAPULAR 2 0.0001
463 THROAT IRRITATION 4 0.0001
464 BLOOD CALCIUM DECREASED 1 0.0001
465 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
466 CHEST DISCOMFORT 9 0.0001
467 ASTHENIA 33 0.0001
468 PRODUCT SUBSTITUTION ISSUE 5 0.0001
469 NASOPHARYNGITIS 16 0.0001
470 CAESAREAN SECTION 1 0.0001
471 PRODUCT PRESCRIBING ERROR 2 0.0001
472 MYOCLONUS 1 0.0001
473 JOINT SWELLING 10 0.0001
474 MUSCLE SPASTICITY 1 0.0001
475 CARDIOMEGALY 1 0.0001
476 ILEUS 1 0.0001
477 WEIGHT INCREASED 18 0.0001
478 DRY EYE 4 0.0001
479 HALLUCINATION 6 0.0001
480 DERMATITIS ALLERGIC 1 0.0001
481 INJECTION SITE IRRITATION 1 0.0001
482 PAIN 48 0.0001
483 INFUSION SITE PAIN 1 0.0001
484 SKIN ULCER 2 0.0001
485 MUSCLE SPASMS 14 0.0001
486 HAND DEFORMITY 1 0.0001
487 ANHEDONIA 2 0.0001
488 ORAL CANDIDIASIS 1 0.0001
489 PULMONARY CONGESTION 1 0.0001
490 CONDITION AGGRAVATED 23 0.0001
491 DYSMENORRHOEA 1 0.0001
492 FEELING ABNORMAL 18 0.0001
493 ABORTION SPONTANEOUS 3 0.0001
494 HAIR TEXTURE ABNORMAL 1 0.0001
495 MALIGNANT MELANOMA 1 0.0001
496 QUALITY OF LIFE DECREASED 1 0.0001
497 JAUNDICE 2 0.0001
498 DISTURBANCE IN ATTENTION 4 0.0001
499 DRY MOUTH 6 0.0001
500 PSORIATIC ARTHROPATHY 3 0.0001
501 CONSTIPATION 16 0.0001
502 PERIPHERAL COLDNESS 1 0.0001
503 APHONIA 1 0.0001
504 ABDOMINAL DISCOMFORT 12 0.0001
505 BLISTER 4 0.0001
506 DEVICE OCCLUSION 1 0.0001
507 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
508 BLINDNESS UNILATERAL 1 0.0001
509 FATIGUE 55 0.0001
510 INTENTIONAL DOSE OMISSION 2 0.0001
511 HYPERHIDROSIS 9 0.0001
512 IMPAIRED QUALITY OF LIFE 1 0.0001
513 HYPOKINESIA 1 0.0001
514 APATHY 1 0.0001
515 MUSCULOSKELETAL STIFFNESS 6 0.0001
516 DRUG WITHDRAWAL SYNDROME 6 0.0001
517 ACUTE MYOCARDIAL INFARCTION 2 0.0001
518 PSYCHOTIC DISORDER 2 0.0001
519 TACHYCARDIA 6 0.0001
520 SKIN HAEMORRHAGE 1 0.0001
521 IMMUNODEFICIENCY 1 0.0001
522 ABDOMINAL DISTENSION 7 0.0001
523 HOT FLUSH 5 0.0001
524 HYPERTENSION 14 0.0001
525 ECONOMIC PROBLEM 1 0.0001
526 OSTEOPENIA 1 0.0001
527 SUICIDAL IDEATION 6 0.0001
528 MEMORY IMPAIRMENT 9 0.0001
529 INSURANCE ISSUE 1 0.0001
530 HIP ARTHROPLASTY 1 0.0001
531 THYROID DISORDER 1 0.0001
532 EMOTIONAL DISORDER 2 0.0001
533 TENDONITIS 1 0.0001
534 SOMNOLENCE 13 0.0001
535 CYANOSIS 1 0.0001
536 NEUROPATHY PERIPHERAL 6 0.0001
537 PNEUMOTHORAX 1 0.0001
538 DRUG INTERACTION 10 0.0001
539 SCIATICA 1 0.0001
540 HYPOTHYROIDISM 2 0.0001
541 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
542 CONTUSION 6 0.0001
543 SENSORY DISTURBANCE 1 0.0001
544 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
545 BACK DISORDER 1 0.0001
546 METASTASES TO BONE 1 0.0001
547 MULTIPLE FRACTURES 1 0.0001
548 MANIA 1 0.0001
549 INFLUENZA LIKE ILLNESS 5 0.0001
550 VENTRICULAR TACHYCARDIA 1 0.0001
551 PHOTOSENSITIVITY REACTION 1 0.0001
552 TREMOR 10 0.0001
553 SYNCOPE 6 0.0001
554 GAIT INABILITY 2 0.0001
555 VOMITING 28 0.0001
556 PERICARDITIS 1 0.0001
557 ANGER 2 0.0001
558 HEMIPARESIS 1 0.0001
559 INJECTION SITE PAIN 18 0.0001
560 SCAR 1 0.0001
561 VISION BLURRED 8 0.0001
562 PARANOIA 1 0.0001
563 NIGHTMARE 2 0.0001
564 BURNING SENSATION 4 0.0001
565 AMENORRHOEA 1 0.0001
566 HEART RATE DECREASED 2 0.0001
567 DEPRESSED MOOD 3 0.0001
568 LYMPHADENOPATHY 2 0.0001
569 ALOPECIA 11 0.0001
570 SYNOVITIS 1 0.0001
571 COMPLICATION OF DEVICE REMOVAL 1 0.0001
572 TOOTHACHE 1 0.0001
573 DRUG EFFECT INCOMPLETE 2 0.0001
574 PELVIC PAIN 1 0.0001
575 RESTLESS LEGS SYNDROME 1 0.0001
576 END STAGE RENAL DISEASE 1 0.0001
577 RESTLESSNESS 2 0.0001
578 ADVERSE EVENT 5 0.0001
579 CONJUNCTIVITIS 1 0.0001
580 DYSGEUSIA 4 0.0001
581 DYSARTHRIA 2 0.0001
582 DYSPNOEA EXERTIONAL 2 0.0001
583 ARTHRALGIA 22 0.0001
584 FRACTURE 1 0.0001
585 FOOT FRACTURE 1 0.0001
586 CHRONIC KIDNEY DISEASE 4 0.0001
587 INCORRECT DOSE ADMINISTERED 12 0.0001
588 SLEEP APNOEA SYNDROME 1 0.0001
589 INCREASED APPETITE 1 0.0001
590 HERPES ZOSTER 3 0.0001
591 PULMONARY FIBROSIS 1 0.0001
592 SEROTONIN SYNDROME 1 0.0001
593 LOWER LIMB FRACTURE 1 0.0001
594 PRURITUS 20 0.0001
595 HERNIA 1 0.0001
596 ERUCTATION 1 0.0001
597 COVID-19 9 0.0001
598 SURGERY 3 0.0001
599 SKIN FISSURES 1 0.0001
600 PRODUCT DOSE OMISSION ISSUE 15 0.0001
601 MENORRHAGIA 1 0.0001
602 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
603 CATARACT 3 0.0001
604 UPPER LIMB FRACTURE 1 0.0001
605 MALAISE 22 0.0001
606 DIZZINESS 25 0.0001
607 IRRITABILITY 3 0.0000
608 PRODUCT PHYSICAL ISSUE 1 0.0000
609 PRODUCT ADMINISTRATION ERROR 1 0.0000
610 FEEDING DISORDER 1 0.0000
611 TASTE DISORDER 1 0.0000
612 RIB FRACTURE 1 0.0000
613 INJECTION SITE ERYTHEMA 6 0.0000
614 TOOTH LOSS 1 0.0000
615 RETCHING 1 0.0000
616 URINARY TRACT INFECTION 8 0.0000
617 JOINT INJURY 1 0.0000
618 IRRITABLE BOWEL SYNDROME 1 0.0000
619 LIVER FUNCTION TEST INCREASED 1 0.0000
620 POOR QUALITY SLEEP 1 0.0000
621 PRURITUS GENERALISED 1 0.0000
622 PYREXIA 16 0.0000
623 PRODUCT DOSE OMISSION 3 0.0000
624 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
625 LIVER DISORDER 2 0.0000
626 DEHYDRATION 6 0.0000
627 STEVENS-JOHNSON SYNDROME 1 0.0000
628 HYPOTENSION 9 0.0000
629 GLOSSODYNIA 1 0.0000
630 ORAL PAIN 1 0.0000
631 ADVERSE DRUG REACTION 4 0.0000
632 PANCREATITIS ACUTE 1 0.0000
633 APPLICATION SITE PRURITUS 1 0.0000
634 MUSCULAR WEAKNESS 5 0.0000
635 ABDOMINAL PAIN UPPER 9 0.0000
636 SKIN DISCOLOURATION 2 0.0000
637 MUSCLE TWITCHING 1 0.0000
638 HYPOKALAEMIA 2 0.0000
639 CONFUSIONAL STATE 7 0.0000
640 CARDIAC DISORDER 4 0.0000
641 PALPITATIONS 5 0.0000
642 SLEEP DISORDER 3 0.0000
643 DISEASE RECURRENCE 2 0.0000
644 PNEUMONIA 13 0.0000
645 FLUID RETENTION 2 0.0000
646 ACUTE KIDNEY INJURY 6 0.0000
647 HYPOPHAGIA 1 0.0000
648 HAEMOGLOBIN DECREASED 4 0.0000
649 ILLNESS 4 0.0000
650 ANAPHYLACTIC SHOCK 1 0.0000
651 DECREASED APPETITE 9 0.0000
652 EXPOSURE VIA SKIN CONTACT 1 0.0000
653 DEAFNESS 1 0.0000
654 SPEECH DISORDER 2 0.0000
655 ARTHRITIS 3 0.0000
656 JOINT STIFFNESS 1 0.0000
657 DERMATITIS ATOPIC 2 0.0000
658 INJECTION SITE HAEMORRHAGE 3 0.0000
659 MENSTRUATION IRREGULAR 1 0.0000
660 FEAR 1 0.0000
661 RASH PRURITIC 2 0.0000
662 OEDEMA 2 0.0000
663 LIMB INJURY 1 0.0000
664 GAIT DISTURBANCE 7 0.0000
665 CARDIAC ARREST 3 0.0000
666 RESPIRATORY ARREST 1 0.0000
667 DIVERTICULITIS 1 0.0000
668 PROCEDURAL PAIN 1 0.0000
669 ARTHROPATHY 2 0.0000
670 INFLUENZA 4 0.0000
671 HAEMOPTYSIS 1 0.0000
672 URTICARIA 6 0.0000
673 WOUND 1 0.0000
674 RENAL IMPAIRMENT 3 0.0000
675 OXYGEN SATURATION DECREASED 2 0.0000
676 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
677 MYALGIA 6 0.0000
678 RHEUMATOID ARTHRITIS 4 0.0000
679 RED BLOOD CELL COUNT DECREASED 1 0.0000
680 BALANCE DISORDER 3 0.0000
681 BONE PAIN 2 0.0000
682 PAIN IN EXTREMITY 10 0.0000
683 URINARY INCONTINENCE 1 0.0000
684 BLOOD POTASSIUM DECREASED 1 0.0000
685 PREMATURE BABY 1 0.0000
686 APHASIA 1 0.0000
687 FALL 11 0.0000
688 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
689 OEDEMA PERIPHERAL 4 0.0000
690 BLOOD PRESSURE INCREASED 5 0.0000
691 OROPHARYNGEAL PAIN 3 0.0000
692 VISUAL IMPAIRMENT 4 0.0000
693 EXPOSURE DURING PREGNANCY 2 0.0000
694 SWELLING 3 0.0000
695 NERVOUS SYSTEM DISORDER 1 0.0000
696 BONE DENSITY DECREASED 1 0.0000
697 PULMONARY EMBOLISM 3 0.0000
698 MOOD SWINGS 1 0.0000
699 MOVEMENT DISORDER 1 0.0000
700 NIGHT SWEATS 1 0.0000
701 OSTEONECROSIS 1 0.0000
702 EYE DISORDER 1 0.0000
703 DEVICE DIFFICULT TO USE 2 0.0000
704 BLOOD PRESSURE DECREASED 2 0.0000
705 EXPIRED PRODUCT ADMINISTERED 1 0.0000
706 VIRAL INFECTION 1 0.0000
707 HEPATIC ENZYME INCREASED 2 0.0000
708 GASTRIC DISORDER 1 0.0000
709 NEOPLASM PROGRESSION 1 0.0000
710 HYPOXIA 1 0.0000
711 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
712 PRODUCT ADHESION ISSUE 1 0.0000
713 THERAPY INTERRUPTED 2 0.0000
714 CEREBRAL HAEMORRHAGE 1 0.0000
715 SKIN BURNING SENSATION 2 0.0000
716 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
717 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
718 CRYING 1 0.0000
719 UNDERDOSE 2 0.0000
720 ACCIDENTAL OVERDOSE 1 0.0000
721 INJECTION SITE MASS 1 0.0000
722 CHEST PAIN 5 0.0000
723 INTESTINAL OBSTRUCTION 1 0.0000
724 PERIPHERAL SWELLING 4 0.0000
725 BACK PAIN 6 0.0000
726 DISORIENTATION 1 0.0000
727 RASH 11 0.0000
728 CARDIAC FAILURE CONGESTIVE 2 0.0000
729 DEVICE BREAKAGE 1 0.0000
730 ERYTHEMA 5 0.0000
731 POLLAKIURIA 1 0.0000
732 ROAD TRAFFIC ACCIDENT 1 0.0000
733 SKIN EXFOLIATION 2 0.0000
734 OSTEOARTHRITIS 1 0.0000
735 DEVICE LEAKAGE 1 0.0000
736 VAGINAL HAEMORRHAGE 1 0.0000
737 RENAL FAILURE 3 0.0000
738 DRY SKIN 3 0.0000
739 PULMONARY OEDEMA 1 0.0000
740 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
741 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
742 THERAPY NON-RESPONDER 1 0.0000
743 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
744 RENAL DISORDER 1 0.0000
745 ARRHYTHMIA 1 0.0000
746 RASH ERYTHEMATOUS 1 0.0000
747 BLOOD GLUCOSE DECREASED 1 0.0000
748 INTERSTITIAL LUNG DISEASE 1 0.0000
749 ATRIAL FIBRILLATION 2 0.0000
750 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
751 THERAPY CESSATION 1 0.0000
752 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
753 INFLAMMATION 1 0.0000
754 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
755 HAEMORRHAGE 2 0.0000
756 ECZEMA 1 0.0000
757 PANCREATITIS 1 0.0000
758 BRADYCARDIA 1 0.0000
759 DRUG EFFECT DECREASED 1 0.0000
760 ANAPHYLACTIC REACTION 1 0.0000
761 MEDICATION ERROR 1 0.0000
762 SEPSIS 2 0.0000
763 CEREBROVASCULAR ACCIDENT 3 0.0000
764 FLATULENCE 1 0.0000
765 CONVULSION 1 0.0000
766 LETHARGY 1 0.0000
767 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
768 CHILLS 2 0.0000
769 EMOTIONAL DISTRESS 2 0.0000
770 THERAPEUTIC RESPONSE DECREASED 1 0.0000
771 STOMATITIS 1 0.0000
772 DISCOMFORT 1 0.0000
773 ANAEMIA 3 0.0000
774 DEVICE EXPULSION 1 0.0000
775 DEEP VEIN THROMBOSIS 1 0.0000
776 BLOOD CREATININE INCREASED 1 0.0000
777 PSORIASIS 2 0.0000
778 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
779 DEVICE MALFUNCTION 1 0.0000
780 INJURY 1 0.0000
781 OVERDOSE 3 0.0000
782 INFECTION 2 0.0000
783 AGITATION 1 0.0000
784 EPISTAXIS 1 0.0000
785 UNEVALUABLE EVENT 1 0.0000
786 ACNE 1 0.0000
787 HOSPITALISATION 2 0.0000
788 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
789 MYOCARDIAL INFARCTION 2 0.0000
790 PRODUCT STORAGE ERROR 1 0.0000
791 INTENTIONAL PRODUCT MISUSE 1 0.0000
792 GASTROINTESTINAL DISORDER 1 0.0000
793 DEVICE ISSUE 1 0.0000
794 DYSPHAGIA 1 0.0000
795 PLATELET COUNT DECREASED 1 0.0000
796 PRODUCT QUALITY ISSUE 1 0.0000
797 DRUG DEPENDENCE 1 0.0000
798 DRUG DOSE OMISSION 1 0.0000
799 TOXICITY TO VARIOUS AGENTS 1 0.0000
800 NO ADVERSE EVENT 1 0.0000
801 DEATH 2 0.0000